Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor J Lockett

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
BMC Chemical Biology|December 14, 2004
Redesigned and chemically-modified hammerhead ribozymes with improved activity and serum stabilityPhilip Hendry, Maxine J McCall, Tom S Stewart, et al.
Statistics in Medicine|April 9, 2015
A prediction model for colon cancer surveillance dataNorm M Good, Krithika Suresh, Graeme P Young, et al.
Journal of Gastroenterology and Hepatology|January 23, 2015
Ideal colonoscopic surveillance intervals to reduce incidence of advanced adenoma and colorectal cancerNorm M Good, Finlay A Macrae, Graeme P Young, et al.
Clinical and Experimental Pharmacology & Physiology|May 26, 2010
Structure-activity relationship of butyrate analogues on apoptosis, proliferation and histone deacetylase activity in HCT-116 human colorectal cancer cellsCheng Cheng Ooi, Norm M Good, Desmond B Williams, et al.
The British Journal of Nutrition|February 26, 2015
Bioequivalence of n-3 fatty acids from microencapsulated fish oil formulations in human subjectsLuz Sanguansri, Mary Ann Augustin, Trevor J Lockett, et al.
Clinical and Experimental Pharmacology & Physiology|November 26, 2009
Efficacy of butyrate analogues in HT-29 cancer cellsCheng C Ooi, Norm M Good, Desmond B Williams, et al.
Mutation Research|February 8, 2011
Is the tissue persistence of O(6)-methyl-2'-deoxyguanosine an indicator of tumour formation in the gastrointestinal tract?Shir Ley Tan, Jacobus P Gerber, Leah J Cosgrove, et al.
Cancer Biology & Therapy|December 9, 2014
Butyrylated starch affects colorectal cancer markers beneficially and dose-dependently in genotoxin-treated ratsShusuke Toden, Trevor J Lockett, David L Topping, et al.
Carcinogenesis|November 15, 2011
Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated ratsJulie M Clarke, Graeme P Young, David L Topping, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|October 22, 2013
Repair and removal of azoxymethane-induced O6-methylguanine in rat colon by O6-methylguanine DNA methyltransferase and apoptosisLaura S Nyskohus, Amanda J Watson, Geoffrey P Margison, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
BMC Chemical Biology|December 14, 2004
Redesigned and chemically-modified hammerhead ribozymes with improved activity and serum stabilityPhilip Hendry, Maxine J McCall, Tom S Stewart, et al.
Statistics in Medicine|April 9, 2015
A prediction model for colon cancer surveillance dataNorm M Good, Krithika Suresh, Graeme P Young, et al.
Journal of Gastroenterology and Hepatology|January 23, 2015
Ideal colonoscopic surveillance intervals to reduce incidence of advanced adenoma and colorectal cancerNorm M Good, Finlay A Macrae, Graeme P Young, et al.
Clinical and Experimental Pharmacology & Physiology|May 26, 2010
Structure-activity relationship of butyrate analogues on apoptosis, proliferation and histone deacetylase activity in HCT-116 human colorectal cancer cellsCheng Cheng Ooi, Norm M Good, Desmond B Williams, et al.
The British Journal of Nutrition|February 26, 2015
Bioequivalence of n-3 fatty acids from microencapsulated fish oil formulations in human subjectsLuz Sanguansri, Mary Ann Augustin, Trevor J Lockett, et al.
Clinical and Experimental Pharmacology & Physiology|November 26, 2009
Efficacy of butyrate analogues in HT-29 cancer cellsCheng C Ooi, Norm M Good, Desmond B Williams, et al.
Mutation Research|February 8, 2011
Is the tissue persistence of O(6)-methyl-2'-deoxyguanosine an indicator of tumour formation in the gastrointestinal tract?Shir Ley Tan, Jacobus P Gerber, Leah J Cosgrove, et al.
Cancer Biology & Therapy|December 9, 2014
Butyrylated starch affects colorectal cancer markers beneficially and dose-dependently in genotoxin-treated ratsShusuke Toden, Trevor J Lockett, David L Topping, et al.
Carcinogenesis|November 15, 2011
Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated ratsJulie M Clarke, Graeme P Young, David L Topping, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|October 22, 2013
Repair and removal of azoxymethane-induced O6-methylguanine in rat colon by O6-methylguanine DNA methyltransferase and apoptosisLaura S Nyskohus, Amanda J Watson, Geoffrey P Margison, et al.
Pageof 3